Fuji Pharma Co., Ltd. (FRA:FUP)

Market Cap	314.92M +56.2%
Revenue (ttm)	296.46M +12.8%
Net Income	12.67M -47.0%
EPS	0.52 -47.2%
Shares Out	n/a
PE Ratio	24.85
Forward PE	n/a
Dividend	0.27 (2.15%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	n/a
Open	12.20
Previous Close	12.10
Day's Range	12.20 - 12.20
52-Week Range	7.60 - 13.60
Beta	n/a
RSI	39.70
Earnings Date	May 7, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, ...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 1,760
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FUP

Financial Performance

In fiscal year 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.

Financial numbers in JPY